CEO Rohan Greenland details the upcoming handover of the Blueprint for a National Action Plan for Neurological Conditions, a prod to government to recognise both the obligation and the economic…
A new Australian study shows COVID-19 boosters improve protection against new variants for people with MS, even when taking immune-suppressing treatments….
The Pharmaceutical Benefits Advisory Committee has recommended subcutaneous ocrelizumab (Ocrevus®) be listed on the PBS for treating relapsing remitting MS….
The Government has announced changes to the NDIS aimed at slowing growth and making the scheme more sustainable. What are those changes and how will they impact Australians living with…
A world-first Australian study is using DNA to identify a person’s genetic risk of developing multiple sclerosis (MS) to understand how their immune system responds to a common virus linked…
MS Australia is calling on the government to improve the aged care system to better meet the needs of older people with disability and reaffirm their commitment to reduce wait…
CEO Rohan Greenland reveals the upcoming launch of a national blueprint for neurological conditions, designed to prompt the Australian Government to finally deliver an action plan for the 7 million…
CEO Rohan Greenland responds to the latest NDIS pricing decision, warning it threatens access to essential therapies and places additional pressure on MS Member Organisations already going above and beyond….
